Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (134)
- Compliance and enforcement (34)
- Import and export (34)
- Shortages and supply disruptions (17)
- Sunscreens (10)
- Advertising (6)
- COVID-19 (5)
- Weight loss products (5)
- Labelling and packaging (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1305 result(s) found, displaying 701 to 725
-
Safety alertsGolden Root complex capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.
-
Market actionsRecall for product correction due to potential for interruption of insulin delivery and/or infection due to needle breaking during use.
-
Market actionsRecall for product correction due to increased risk of death for patients with symptomatic chronic heart failure.
-
Market actionsMultiple devices which use auto servo ventilation/Adaptive Servo-Ventilation (ASV) therapy have been subject to recall actions.
-
Safety alertsThe TGA has reviewed laparoscopic power morcellators and updated safety information to ensure their use aligns with current advice, including warnings about cancer risks and the need for containment systems during surgery.
-
Safety alertsJa Dera 100% Natural Weight Loss Supplement capsules pose a serious risk to your health and should not be taken. They contain undeclared sibutramine. This increases the risk of major cardiac events.
-
Safety alertsNo evidence to support routine blood monitoring at this time
-
Safety alertsSlim Fit capsules pose a serious risk to your health and should not be taken. They contain undeclared sibutramine. This increases the risk of major cardiac events.
-
Market actionsRecall for product correction due to additional affected devices.
-
-
Market actionsRecall as pumps will cease operation on 1 January 2016.
-
Market actionsRecall - risk of adverse events due to unacceptably high level of arsenic
-
Safety alertsUpdate - adverse event monitoring
-
Market actionsHazard alert due to multiple potential safety issues.
-
Market actionsRecall for product correction due to fire risk from faulty component.
-
Market actionsRecall for product correction due to fire risk from faulty component.
-
Market actionsThe following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall for product correction due to risk of sparking or fire due to damaged or cut wire.
-
Safety alertsMMC USA Blue Shark capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.
-
Market actionsRecall due to counterfeit products may have defects and not be effective.
-
Market actionsRecall for product correction due to potential for insulin to not be delivered as intended.
-
Market actionsUpdate - recall for product correction - advertisements published to inform all affected users
-
Safety alertsUSA Gold Ant capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil. They have not been assessed for quality, safety or efficacy.
-
Safety alertsStrong Horses capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.